RenovoRx appoints Ramtin Agah, MD as Executive Chairman; $450K salary + bonus

RenovoRx, Inc.

Ramtin Agah, MD appointed Executive Chairman effective Feb 27, 2026; continues as Chief Medical Officer.
$450,000 annual base salary, discretionary bonus up to 40% of base (first bonus payable in 2027 for 2026).
Eligible for annual grants of stock options and other equity awards under Company's 2021 Omnibus Equity Incentive Plan.
Employment at-will; prior consulting agreement replaced; existing Change in Control and Severance Agreement remains in effect.
CEO Shaun Bagai remains principal executive officer; Dr. Agah reports directly to Board.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.